ADRB1
Beta-1 adrenergic receptor
Also known as: ADRB1_HUMAN, ADRB1R
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08588
- Gene
- ADRB1
- Ensembl
- ENSG00000043591
- Chromosome
- 10
- Canonical length
- 477 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The adrenergic receptors (subtypes alpha 1, alpha 2, beta 1, and beta 2) are a prototypic family of guanine nucleotide binding regulatory protein-coupled receptors that mediate the physiological effects of the hormone epinephrine and the neurotransmitter norepinephrine. Beta-1 adrenoceptors are predominately located in the heart. Specific polymorphisms in this gene have been shown to affect the resting heart rate and can be involved in heart failure. [provided by RefSeq, Sep 2019]
Canonical amino-acid sequenceUniProt
477 residues, UniProt reviewed canonical sequence.
>P08588|ADRB1
1 MGAGVLVLGA SEPGNLSSAA PLPDGAATAA RLLVPASPPA SLLPPASESP EPLSQQWTAG
61 MGLLMALIVL LIVAGNVLVI VAIAKTPRLQ TLTNLFIMSL ASADLVMGLL VVPFGATIVV
121 WGRWEYGSFF CELWTSVDVL CVTASIETLC VIALDRYLAI TSPFRYQSLL TRARARGLVC
181 TVWAISALVS FLPILMHWWR AESDEARRCY NDPKCCDFVT NRAYAIASSV VSFYVPLCIM
241 AFVYLRVFRE AQKQVKKIDS CERRFLGGPA RPPSPSPSPV PAPAPPPGPP RPAAAAATAP
301 LANGRAGKRR PSRLVALREQ KALKTLGIIM GVFTLCWLPF FLANVVKAFH RELVPDRLFV
361 FFNWLGYANS AFNPIIYCRS PDFRKAFQGL LCCARRAARR RHATHGDRPR ASGCLARPGP
421 PPSPGAASDD DDDDVVGATP PARLLEPWAG CNGGAAADSD SSLDEPCRPG FASESKVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADRB1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- placenta: 27 nTPM
- heart muscle: 20 nTPM
- lung: 11 nTPM
- basal ganglia: 10 nTPM
- cerebral cortex: 7.9 nTPM
- salivary gland: 5 nTPM
Single-cell type
- cytotrophoblasts: 100 nCPM
- migrating cytotrophoblasts: 57 nCPM
- respiratory ionocytes: 43 nCPM
- syncytiotrophoblasts: 37 nCPM
- alveolar cells type 1: 36 nCPM
- respiratory ciliated cells: 35 nCPM
Immune cell
- myeloid DC: 0.3 nTPM
- classical monocyte: 0.1 nTPM
- intermediate monocyte: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebral cortex: 30 nTPM
- basal ganglia: 26 nTPM
- white matter: 22 nTPM
- amygdala: 16 nTPM
- thalamus: 16 nTPM
- hippocampal formation: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADRB1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 74 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- SHORT SLEEP, FAMILIAL NATURAL, 2
Disease | ImmuneIEDB
Conditions an epitope on ADRB1 was assayed in.
- myocardial infarction T cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against ADRB1 are reported. Each links to that disease's full target list.
Showing 0 of 4 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for ADRB1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
74 publications
- The beta-adrenergic receptors.
2002 · Herz · RCR 5.1 · 207 citations - Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy.
1997 · Circulation · RCR 4 · 135 citations - Oroxin B Resembles Bisoprolol in Attenuating Beta1-Adrenergic Receptor Autoantibody-Induced Atrial Remodelling via the PTEN/AKT/mTOR Signalling Pathway.
2025 · Clin Exp Pharmacol Physiol · RCR 2.8 · 8 citations - Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus.
1997 · Proc Natl Acad Sci U S A · RCR 2.5 · 86 citations - Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy.
2006 · Am Heart J · RCR 2.3 · 103 citations
Show 20 more of 74 total
- Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta andrenergic receptors.
2006 · Heart Rhythm · RCR 2.3 · 84 citations - Direct detection of antibody concentration and affinity in human serum using microscale thermophoresis.
2012 · Anal Chem · RCR 2.3 · 65 citations - Monoclonal antibodies to beta-adrenergic receptors: use in purification and molecular characterization of beta receptors.
1980 · Proc Natl Acad Sci U S A · RCR 2.2 · 78 citations - Autoimmune dysautonomia in women with silicone breast implants.
2021 · J Autoimmun · RCR 2.1 · 25 citations - Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis.
2007 · Circulation · RCR 2 · 87 citations - Frequency of autoantibodies and their associated clinical characteristics and outcomes in patients with dilated cardiomyopathy: A systematic review and meta-analysis.
2025 · Autoimmun Rev · RCR 2 · 5 citations - Autoimmune mechanisms underlying dilated cardiomyopathy.
2009 · Circ J · RCR 2 · 72 citations - Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy.
2003 · J Autoimmun · RCR 1.9 · 79 citations - Decreased autophagy induced by β1-adrenoceptor autoantibodies contributes to cardiomyocyte apoptosis.
2018 · Cell Death Dis · RCR 1.6 · 35 citations - Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.
2007 · Clin Exp Immunol · RCR 1.6 · 55 citations - A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure.
2007 · J Am Coll Cardiol · RCR 1.6 · 66 citations - Downregulation of beta-adrenergic receptors and signal transduction response in salivary glands of NOD mice.
1994 · Am J Physiol · RCR 1.4 · 44 citations - Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy.
2013 · Eur J Heart Fail · RCR 1.4 · 42 citations - Agonistic anti-beta1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the beta1-adrenergic receptor expression in neonatal rat cardiomyocytes.
1998 · Circulation · RCR 1.2 · 50 citations - Diagnostic and therapeutic aspects of β1-adrenergic receptor autoantibodies in human heart disease.
2014 · Autoimmun Rev · RCR 1.2 · 34 citations - Elevated M2-muscarinic and β1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation.
2015 · Clin Res Cardiol · RCR 1.2 · 33 citations - S100a9 inhibits Atg9a transcription and participates in suppression of autophagy in cardiomyocytes induced by β1-adrenoceptor autoantibodies.
2023 · Cell Mol Biol Lett · RCR 1.1 · 9 citations - Functional analysis of rabbit anti-peptide antibodies which mimic autoantibodies against the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.
1991 · J Autoimmun · RCR 1.1 · 35 citations - β2-adrenergic receptor autoantibodies alleviated myocardial damage induced by β1-adrenergic receptor autoantibodies in heart failure.
2018 · Cardiovasc Res · RCR 1.1 · 26 citations - The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease.
2013 · Clin Rev Allergy Immunol · RCR 1.1 · 31 citations
Reference: T cellIEDB
1 publication
- Identification of a novel cardiac epitope triggering T-cell responses in patients with myocardial infarction.
2022 · J Mol Cell Cardiol · RCR 1.2 · 18 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.54
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.7
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating adrenergic receptor signaling pathway
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- brown fat cell differentiation
- diet induced thermogenesis
- fear response
- heat generation
- negative regulation of multicellular organism growth
- norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure
- positive regulation of cardiac muscle cell apoptotic process
- positive regulation of cold-induced thermogenesis
- positive regulation of heart rate by epinephrine-norepinephrine
- positive regulation of MAPK cascade
- positive regulation of the force of heart contraction by epinephrine-norepinephrine
- regulation of circadian sleep/wake cycle, sleep
- response to cold
Molecular functions
- alpha-2A adrenergic receptor binding
- beta-adrenergic receptor activity
- G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential
- PDZ domain binding
- protein heterodimerization activity
- beta1-adrenergic receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADRB1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADRB1 as an antibody target. Whether an autoantibody or antibody against ADRB1 could matter depends on whether native ADRB1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADRB1 is annotated at the cell surface, where native ADRB1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADRB1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...